Research Article

Exploring the Antiovarian Cancer Mechanisms of Salvia Miltiorrhiza Bunge by Network Pharmacological Analysis and Molecular Docking

Table 3

Molecular docking results.

Target namePDB IDCompoundMol IDBinding energy

HSP90AA15FWK1-methyl-8,9-dihydro-7H-naphtho[5,6-g]benzofuran-6,10,11-trioneMOL007127-7.11
HSP90AA15FWKEpidanshenspiroketallactoneMOL007105-6.88
HSP90AA15FWKdihydrotanshinoneIMOL007101-6.57
HSP90AA15FWKNeocryptotanshinone iiMOL007124-5.87
HSP90AA15FWKLuteolinMOL000006-4.54
HSP90AA15FWK2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofurancarboxaldehydeMOL007050-4.12
PIK3CG2A4Z1-methyl-8,9-dihydro-7H-naphtho[5,6-g]benzofuran-6,10,11-trioneMOL007127-7.99
PIK3CG2A4ZdihydrotanshinoneIMOL007101-7.78
PIK3CG2A4ZLuteolinMOL000006-6.51
CDK22CCHEpidanshenspiroketallactoneMOL007105-8.35
CDK22CCHNeocryptotanshinone iiMOL007124-7.89
CDK22CCHMiltionone IMOL007119-7.42
CDK22CCHIsotanshinone IIMOL007111-7.28
CDK22CCH2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofurancarboxaldehydeMOL007050-4.36
GSK3B4AFJMiltionone IMOL007119-6.77
GSK3B4AFJIsotanshinone IIMOL007111-6.7
GSK3B4AFJNeocryptotanshinone iiMOL007124-6.32
GSK3B4AFJ2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxypropyl)-7-methoxy-3-benzofurancarboxaldehydeMOL007050-4
RELA1NFICryptotanshinoneMOL007088-7.06
RELA1NFITanshinone iiaMOL007154-6.44
RELA1NFILuteolinMOL000006-5.59
TP532K8FTanshinone iiaMOL007154-5.4
TP532K8FLuteolinMOL000006-3.75
CDKN1A2ZVWTanshinone iiaMOL007154-5.71
CDKN1A2ZVWLuteolinMOL000006-4.63
BCL2L14CINCryptotanshinoneMOL007088-6.12
BCL2L14CINLuteolinMOL000006-3.89
CCND12 W96CryptotanshinoneMOL007088-7.56
CCND12 W96LuteolinMOL000006-4.93
IL27AH1LuteolinMOL000006-4.38

Molecular docking results between representative SMB active ingredients and the PI3K-Akt signaling pathway targets. And it listed the binding energy.